The AMM measure assesses adults 18 of age and older with a diagnosis of major depression, who were newly treated with antidepressant medication and remained on their antidepressant medications. Two rates are reported: Effective Acute Phase Treatment: Adults who remained on an antidepressant medication for at least 84 days (12 weeks). Effective Continuation Treatment: Adults who remained on an antidepressant medication for at least 180 days (6 months). The tables that follow depict MCO performance on the AMM measures in 2017. As previously mentioned, these data reflect 2016 performance. Exhibit 45: HEDIS 2017 AMM Acute Treatment Rates by MCO Exhibit 46: 2017 AMM Continuous Treatment Rates by MCO The tables below depict trended AMM performance by MCO. The performance trend line and the plan’s 2017 Quality Compass percentile ranking are included for comparison purposes. Exhibit 47: Trended AMM Acute Treatment Performance by MCO Linear 2017 QC HEDIS HEDIS HEDIS HEDIS Performance Percentile 2013 2014 2015 2016 2017 Trend Line Ranking HEDIS 90th 61.03% 59.92% 62.56% 67.57% 64.15% BMCHP 44.94% 42.35% 44.25% 44.85% 44.74% 10th 25th – (%) CeltiCare - - 44.21% 43.88% 47.56% 10th 25th ↑ – Fallon 52.14% 38.80% 51.23% 49.73% 51.74% 33rd 50th ↑ – HNE 51.19% 39.31% 47.11% 46.12% 42.55% 5th 10th ↓ – AMM NHP 46.51% 45.71% 48.47% 48.96% 50.93% 33rd 50th ↑ – Tufts 56.62% 56.30% 58.01% 55.37% 58.09% 75th 90th –
The AMM measure assesses adults 18 of age and older with a diagnosis of major depression, who were newly treated with antidepressant medication and remained on their antidepressant medications. Two rates are reported: Effective Acute Phase Treatment: Adults who remained on an antidepressant medication for at least 84 days (12 weeks). Effective Continuation Treatment: Adults who remained on an antidepressant medication for at least 180 days (6 months). The tables that follow depict MCO performance on the AMM measures in 2017. As previously mentioned, these data reflect 2016 performance. Exhibit 45: HEDIS 2017 AMM Acute Treatment Rates by MCO Exhibit 46: 2017 AMM Continuous Treatment Rates by MCO The tables below depict trended AMM performance by MCO. The performance trend line and the plan’s 2017 Quality Compass percentile ranking are included for comparison purposes. Exhibit 47: Trended AMM Acute Treatment Performance by MCO 2013 HEDIS 2014 HEDIS 2015 HEDIS 2016 HEDIS 2017 Linear Performance Trend Line 2017 QC Percentile Ranking AMM (%) HEDIS 90th 61.03% 59.92% 62.56% 67.57% 64.15% BMCHP 44.94% 42.35% 44.25% 44.85% 44.74% 10th – 25th CeltiCare - - 44.21% 43.88% 47.56% ↑ 10th – 25th Fallon 52.14% 38.80% 51.23% 49.73% 51.74% ↑ 33rd – 50th HNE 51.19% 39.31% 47.11% 46.12% 42.55% ↓ 5th – 10th NHP 46.51% 45.71% 48.47% 48.96% 50.93% ↑ 33rd – 50th Tufts 56.62% 56.30% 58.01% 55.37% 58.09% 75th – 90th